SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Aug 15 3:35 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NeuroInvestment who wrote (978)1/16/1998 12:43:00 AM
From: WeirdPro Randy  Read Replies (1) of 1359
 
On the year end 10-K, under potential products, a drug to deal with alcohol and hepatitis induced cirrhosis was discussed................. Apparently, the company has purchased the exclusive rights to this drug which is currently in phase III studies due for completion in mid-1998.
What is really neat about this is the study is being performed and paid for by the government at VA centers, so IPIC's investment is limited for the development of a potentially huge drug........essentially a different ( and better) type of options deal.......... ........I like how this company works!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News